{{Rsnum
|rsid=8008270
|Gene=FERMT2
|Chromosome=14
|position=52905612
|Orientation=plus
|GMAF=0.1589
|Gene_s=FERMT2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 64.6 | 29.2 | 6.2
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 42.2 | 44.2 | 13.6
| ASW | 57.9 | 35.1 | 7.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 89.1 | 10.9 | 0.0
| LWK | 56.4 | 40.9 | 2.7
| MEX | 86.2 | 12.1 | 1.7
| MKK | 48.7 | 44.2 | 7.1
| TSI | 63.7 | 33.3 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535732
  |Trait=Prostate cancer
  |Title=Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
  |RiskAllele=G
  |Pval=2E-14
  |OR=1.12
  |ORtxt=[1.08-1.16]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}